John Nolan
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA modifications and cancer 4
- RNA Interference and Gene Delivery 4
-
- Cancer, Hypoxia, and Metabolism 5
- MicroRNA in disease regulation 3
- Co-authors
- Matthew A. Naylor (6 shared papers)Ian J. Stratford (7 shared papers)Olga Piskareva (8 shared papers)Michael R.L. Stratford (2 shared papers)Graeme J. Dougherty (1 shared paper)Sally A. Hill (1 shared paper)Gillian M. Tozer (1 shared paper)David C. Blakey (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (5 papers)British Journal of Cancer (4 papers)Cancer Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- United KingdomIrelandUnited States
In The Last Decade
John Nolan
26 papers receiving 772 citations
Peers
Comparison fields: 5 of 79
- Toxicology 98
- Cancer Research 277
- Neurology 116
- Molecular Biology 409
- Organic Chemistry 169
Countries citing papers authored by John Nolan
This map shows the geographic impact of John Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Nolan more than expected).
Fields of papers citing papers by John Nolan
This network shows the impact of papers produced by John Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Nolan. The network helps show where John Nolan may publish in the future.
Co-authors
The 25 scholars most cited alongside John Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. | 2002 | 200 |
| 2 | 2015 | 71 | |
| 3 | 1998 | 63 | |
| 4 | 1988 | 55 | |
| 5 | 2018 | 49 | |
| 6 | 1997 | 48 | |
| 7 | 2020 | 38 | |
| 8 | 2000 | 33 | |
| 9 | 2020 | 20 | |
| 10 | 1999 | 20 | |
| 11 | 2018 | 20 | |
| 12 | 1990 | 19 | |
| 13 | 1990 | 19 | |
| 14 | 1992 | 18 | |
| 15 | 1989 | 17 | |
| 16 | 1991 | 15 | |
| 17 | 1990 | 15 | |
| 18 | 2019 | 15 | |
| 19 | 1989 | 13 | |
| 20 | Indolequinone bioreductive drugs: kinetic factors which influence selectivity for hypoxia. | 1998 | 10 |
About John Nolan
John Nolan is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Neurology and Oncology, having authored 28 papers that have together received 787 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (6 papers), Bioactive Compounds and Antitumor Agents (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (4 papers), RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (3 papers), Virus-based gene therapy research (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Toxicology (98 citations), Cancer Research (277 citations), Neurology (116 citations), Molecular Biology (409 citations) and Organic Chemistry (169 citations). John Nolan has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Matthew A. Naylor, Ian J. Stratford, Olga Piskareva, Michael R.L. Stratford, Graeme J. Dougherty, Sally A. Hill, Gillian M. Tozer, David C. Blakey, Peter D. Davis and Angela Holder. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer, Cancer Letters, Journal of Medicinal Chemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.